Acute Confusional Senile Dementia
|
0.300 |
Biomarker
|
disease |
CTD_human |
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.
|
21460840 |
2011 |
Acute Confusional Senile Dementia
|
0.300 |
Biomarker
|
disease |
CTD_human |
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.
|
21460841 |
2011 |
Acute lymphocytic leukemia
|
0.010 |
PosttranslationalModification
|
disease |
BEFREE |
These results suggest that epigenetic silencing by hypermethylation of EPH/EPHRIN family genes contributes to ALL pathogenesis and that EPHB4 can function as a tumor suppressor in ALL.
|
20061560 |
2010 |
Acute monocytic leukemia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The results showed that expression of all selected Eph receptors was significantly lower in AML patients comparing to controls.
|
24764074 |
2014 |
Adenocarcinoma of lung (disorder)
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The prognostic impact of Eph receptor and ephrin gene expression was analyzed using 2 independent cohorts of lung adenocarcinoma.
|
22807579 |
2012 |
Adenoma of large intestine
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Immunohistochemical staining was used to check the expression of EphA1 protein in 20 colorectal adenomas and in 111 colorectal carcinomas specimens.
|
19011600 |
2009 |
Adult Acute Lymphocytic Leukemia
|
0.010 |
PosttranslationalModification
|
disease |
BEFREE |
These results suggest that epigenetic silencing by hypermethylation of EPH/EPHRIN family genes contributes to ALL pathogenesis and that EPHB4 can function as a tumor suppressor in ALL.
|
20061560 |
2010 |
Adult Glioblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Eph receptors as therapeutic targets in glioblastoma.
|
25144626 |
2014 |
Adult Glioblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Simultaneous targeting of Eph receptors in glioblastoma.
|
27494882 |
2016 |
Adult Medulloblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
We present here the involvement of Eph receptors and ephrin ligands in lung carcinoma, breast carcinoma, prostate carcinoma, colorectal carcinoma, glioblastoma, and medulloblastoma.
|
29682554 |
2018 |
Adult Meningioma
|
0.010 |
Biomarker
|
disease |
BEFREE |
EPH receptor signaling as a novel therapeutic target in NF2-deficient meningioma.
|
29982664 |
2018 |
Age-related cataract
|
0.010 |
Biomarker
|
disease |
BEFREE |
The gene for Eph-receptor tyrosinekinase-type A2 (EPHA2) has been shown to be involved in the pathogenesis of age-related cataract (ARC).
|
21686326 |
2011 |
AIDS related complex
|
0.010 |
Biomarker
|
disease |
BEFREE |
The gene for Eph-receptor tyrosinekinase-type A2 (EPHA2) has been shown to be involved in the pathogenesis of age-related cataract (ARC).
|
21686326 |
2011 |
Alzheimer Disease, Early Onset
|
0.300 |
Biomarker
|
disease |
CTD_human |
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.
|
21460841 |
2011 |
Alzheimer Disease, Early Onset
|
0.300 |
Biomarker
|
disease |
CTD_human |
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.
|
21460840 |
2011 |
Alzheimer Disease, Late Onset
|
0.370 |
Biomarker
|
disease |
BEFREE |
In addition to apolipoprotein E (APOE), recent large genome-wide association studies (GWASs) have identified nine other genes/loci (CR1, BIN1, CLU, PICALM, MS4A4/MS4A6E, CD2AP, CD33, EPHA1 and ABCA7) for late-onset Alzheimer's disease (LOAD).
|
22832961 |
2012 |
Alzheimer Disease, Late Onset
|
0.370 |
Biomarker
|
disease |
BEFREE |
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.
|
21460841 |
2011 |
Alzheimer Disease, Late Onset
|
0.370 |
GeneticVariation
|
disease |
BEFREE |
A stop-gain mutation in ABCA7 (E1679X) and missense mutation in CD2AP (K633R) were highly significant in Caucasian LOAD cases, and mutations in EPHA1 (P460L) and BIN1 (K358R) were significant in Caribbean Hispanic families with LOAD.
|
26101835 |
2015 |
Alzheimer Disease, Late Onset
|
0.370 |
Biomarker
|
disease |
CTD_human |
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.
|
21460841 |
2011 |
Alzheimer Disease, Late Onset
|
0.370 |
Biomarker
|
disease |
BEFREE |
Additionally, nominally significant linkage was observed with RVs in ABCA7, ACE, EPHA1, and SORL1, genes that were previously reported to be associated with LOAD.
|
31585107 |
2019 |
Alzheimer Disease, Late Onset
|
0.370 |
GeneticVariation
|
disease |
BEFREE |
ABCA7 and EphA1 Genes Polymorphisms in Late-Onset Alzheimer's Disease.
|
31659653 |
2020 |
Alzheimer Disease, Late Onset
|
0.370 |
GeneticVariation
|
disease |
BEFREE |
ABCA7-rs3764650-C and EPHA1-rs11767557-A associated with increased rates of memory decline in subjects with a final diagnosis of MCI/LOAD.
|
25189118 |
2015 |
Alzheimer Disease, Late Onset
|
0.370 |
GeneticVariation
|
disease |
BEFREE |
Correction to: ABCA7 and EphA1 Genes Polymorphisms in Late-Onset Alzheimer's Disease.
|
31823285 |
2020 |
Alzheimer Disease, Late Onset
|
0.370 |
Biomarker
|
disease |
CTD_human |
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.
|
21460840 |
2011 |
Alzheimer's Disease
|
0.500 |
Biomarker
|
disease |
CTD_human |
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.
|
21460841 |
2011 |